Status:
COMPLETED
Big Data Analysis of the Use of bIomarkers Concentration
Lead Sponsor:
Hospital Avicenne
Collaborating Sponsors:
Roche Diagnostics GmbH
ProBayes
Conditions:
Biological Markers
Inappropriate Prescribing
Eligibility:
All Genders
20+ years
Brief Summary
The investigators conducted a retrospective analysis of all measured concentrations performed in a large subset of laboratories located in the French Brittany from February 2010 the 17th to August 201...
Detailed Description
The rUBIDIuM study is a retrospective analysis that included all tests (but not including DNA analysis or HIV tests) performed in a large subset of laboratories located in the French Brittany from Feb...
Eligibility Criteria
Inclusion
- All adult patients \>20 that came to a participating lab (Biorance Laboratoires Réunis) during the study period for biological measurement
Exclusion
- DNA analysis, HIV test
Key Trial Info
Start Date :
February 17 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 10 2015
Estimated Enrollment :
585745 Patients enrolled
Trial Details
Trial ID
NCT03254472
Start Date
February 17 2010
End Date
September 10 2015
Last Update
August 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Avicenne Hospital
Bobigny, France, 93000